Christopher C Conlin1, Christine H Feng2, Ana E Rodriguez-Soto1, Roshan A Karunamuni2, Joshua M Kuperman1, Dominic Holland3, Rebecca Rakow-Penner1, Michael E Hahn1, Tyler M Seibert1,2,4, Anders M Dale1,3,5. 1. Department of Radiology, UC San Diego School of Medicine, La Jolla, California, USA. 2. Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, California, USA. 3. Department of Neurosciences, UC San Diego School of Medicine, La Jolla, California, USA. 4. Department of Bioengineering, UC San Diego Jacobs School of Engineering, La Jolla, California, USA. 5. Halıcıoğlu Data Science Institute, UC San Diego, La Jolla, California, USA.
Abstract
BACKGROUND: Multicompartmental modeling outperforms conventional diffusion-weighted imaging (DWI) in the assessment of prostate cancer. Optimized multicompartmental models could further improve the detection and characterization of prostate cancer. PURPOSE: To optimize multicompartmental signal models and apply them to study diffusion in normal and cancerous prostate tissue in vivo. STUDY TYPE: Retrospective. SUBJECTS: Forty-six patients who underwent MRI examination for suspected prostate cancer; 23 had prostate cancer and 23 had no detectable cancer. FIELD STRENGTH/SEQUENCE: 3T multishell diffusion-weighted sequence. ASSESSMENT: Multicompartmental models with 2-5 tissue compartments were fit to DWI data from the prostate to determine optimal compartmental apparent diffusion coefficients (ADCs). These ADCs were used to compute signal contributions from the different compartments. The Bayesian Information Criterion (BIC) and model-fitting residuals were calculated to quantify model complexity and goodness-of-fit. Tumor contrast-to-noise ratio (CNR) and tumor-to-background signal intensity ratio (SIR) were computed for conventional DWI and multicompartmental signal-contribution maps. STATISTICAL TESTS: Analysis of variance (ANOVA) and two-sample t-tests (α = 0.05) were used to compare fitting residuals between prostate regions and between multicompartmental models. T-tests (α = 0.05) were also used to assess differences in compartmental signal-fraction between tissue types and CNR/SIR between conventional DWI and multicompartmental models. RESULTS: The lowest BIC was observed from the 4-compartment model, with optimal ADCs of 5.2e-4, 1.9e-3, 3.0e-3, and >3.0e-2 mm2 /sec. Fitting residuals from multicompartmental models were significantly lower than from conventional ADC mapping (P < 0.05). Residuals were lowest in the peripheral zone and highest in tumors. Tumor tissue showed the largest reduction in fitting residual by increasing model order. Tumors had a greater proportion of signal from compartment 1 than normal tissue (P < 0.05). Tumor CNR and SIR were greater on compartment-1 signal maps than conventional DWI (P < 0.05) and increased with model order. DATA CONCLUSION: The 4-compartment signal model best described diffusion in the prostate. Compartmental signal contributions revealed by this model may improve assessment of prostate cancer. Level of Evidence 3 Technical Efficacy Stage 3 J. MAGN. RESON. IMAGING 2021;53:628-639.
BACKGROUND: Multicompartmental modeling outperforms conventional diffusion-weighted imaging (DWI) in the assessment of prostate cancer. Optimized multicompartmental models could further improve the detection and characterization of prostate cancer. PURPOSE: To optimize multicompartmental signal models and apply them to study diffusion in normal and cancerous prostate tissue in vivo. STUDY TYPE: Retrospective. SUBJECTS: Forty-six patients who underwent MRI examination for suspected prostate cancer; 23 had prostate cancer and 23 had no detectable cancer. FIELD STRENGTH/SEQUENCE: 3T multishell diffusion-weighted sequence. ASSESSMENT: Multicompartmental models with 2-5 tissue compartments were fit to DWI data from the prostate to determine optimal compartmental apparent diffusion coefficients (ADCs). These ADCs were used to compute signal contributions from the different compartments. The Bayesian Information Criterion (BIC) and model-fitting residuals were calculated to quantify model complexity and goodness-of-fit. Tumor contrast-to-noise ratio (CNR) and tumor-to-background signal intensity ratio (SIR) were computed for conventional DWI and multicompartmental signal-contribution maps. STATISTICAL TESTS: Analysis of variance (ANOVA) and two-sample t-tests (α = 0.05) were used to compare fitting residuals between prostate regions and between multicompartmental models. T-tests (α = 0.05) were also used to assess differences in compartmental signal-fraction between tissue types and CNR/SIR between conventional DWI and multicompartmental models. RESULTS: The lowest BIC was observed from the 4-compartment model, with optimal ADCs of 5.2e-4, 1.9e-3, 3.0e-3, and >3.0e-2 mm2 /sec. Fitting residuals from multicompartmental models were significantly lower than from conventional ADC mapping (P < 0.05). Residuals were lowest in the peripheral zone and highest in tumors. Tumor tissue showed the largest reduction in fitting residual by increasing model order. Tumors had a greater proportion of signal from compartment 1 than normal tissue (P < 0.05). Tumor CNR and SIR were greater on compartment-1 signal maps than conventional DWI (P < 0.05) and increased with model order. DATA CONCLUSION: The 4-compartment signal model best described diffusion in the prostate. Compartmental signal contributions revealed by this model may improve assessment of prostate cancer. Level of Evidence 3 Technical Efficacy Stage 3 J. MAGN. RESON. IMAGING 2021;53:628-639.
Authors: Yipeng Hu; Hashim U Ahmed; Tim Carter; Nimalan Arumainayagam; Emilie Lecornet; Winston Barzell; Alex Freeman; Pierre Nevoux; David J Hawkes; Arnauld Villers; Mark Emberton; Dean C Barratt Journal: BJU Int Date: 2012-03-06 Impact factor: 5.588
Authors: Jeffrey C Weinreb; Jelle O Barentsz; Peter L Choyke; Francois Cornud; Masoom A Haider; Katarzyna J Macura; Daniel Margolis; Mitchell D Schnall; Faina Shtern; Clare M Tempany; Harriet C Thoeny; Sadna Verma Journal: Eur Urol Date: 2015-10-01 Impact factor: 20.096
Authors: Eleftheria Panagiotaki; Rachel W Chan; Nikolaos Dikaios; Hashim U Ahmed; James O'Callaghan; Alex Freeman; David Atkinson; Shonit Punwani; David J Hawkes; Daniel C Alexander Journal: Invest Radiol Date: 2015-04 Impact factor: 6.016
Authors: Aritrick Chatterjee; Roger M Bourne; Shiyang Wang; Ajit Devaraj; Alexander J Gallan; Tatjana Antic; Gregory S Karczmar; Aytekin Oto Journal: Radiology Date: 2018-02-02 Impact factor: 11.105
Authors: Caroline M A Hoeks; Eline K Vos; Joyce G R Bomers; Jelle O Barentsz; Christina A Hulsbergen-van de Kaa; Tom W Scheenen Journal: Invest Radiol Date: 2013-10 Impact factor: 6.016
Authors: Ana E Rodríguez-Soto; Maren M Sjaastad Andreassen; Lauren K Fang; Christopher C Conlin; Helen H Park; Grace S Ahn; Hauke Bartsch; Joshua Kuperman; Igor Vidić; Haydee Ojeda-Fournier; Anne M Wallace; Michael Hahn; Tyler M Seibert; Neil Peter Jerome; Agnes Østlie; Tone Frost Bathen; Pål Erik Goa; Rebecca Rakow-Penner; Anders M Dale Journal: Magn Reson Med Date: 2021-12-14 Impact factor: 3.737
Authors: Christine H Feng; Christopher C Conlin; Kanha Batra; Ana E Rodríguez-Soto; Roshan Karunamuni; Aaron Simon; Joshua Kuperman; Rebecca Rakow-Penner; Michael E Hahn; Anders M Dale; Tyler M Seibert Journal: J Magn Reson Imaging Date: 2021-03-31 Impact factor: 5.119
Authors: Alexandra H Besser; Lauren K Fang; Michelle W Tong; Maren M Sjaastad Andreassen; Haydee Ojeda-Fournier; Christopher C Conlin; Stéphane Loubrie; Tyler M Seibert; Michael E Hahn; Joshua M Kuperman; Anne M Wallace; Anders M Dale; Ana E Rodríguez-Soto; Rebecca A Rakow-Penner Journal: Cancers (Basel) Date: 2022-06-30 Impact factor: 6.575